Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Idarubicin × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 35 Myelodysplastic Syndromes 6 Leukemia, Biphenotypic, Acute 5 Leukemia 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelomonocytic, Acute 3 Neoplasm, Residual 2 Myeloproliferative Disorders 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Congenital Abnormalities 2 Sarcoma, Myeloid 1 Neoplasms by Histologic Type 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Hematologic Neoplasms 1 Down Syndrome 1 Carcinoma, Hepatocellular 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Rituximab 41 Cyclophosphamide 31 Lenalidomide 24 fludarabine 19 zanubrutinib 12 venetoclax 11 obinutuzumab 11 fludarabine phosphate 9 Bendamustine Hydrochloride 9 orelabrutinib 8 ibrutinib 8 Vincristine 8 Magnetic Resonance Spectroscopy 8 pirtobrutinib 7 Whole-Body Irradiation 7 Prednisone 7 Specimen Handling 6 Doxorubicin 6 CT-P10 6 Mycophenolic Acid 5 Etoposide 5 Biopsy 5 pembrolizumab 4 Nivolumab 4 Melphalan 4 tafasitamab 3 Sirolimus 3 Cyclosporine 3 parsaclisib 2 copanlisib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡